日本市場個股詳情
4516 日本新藥
- 4154.0
- +136.0+3.38%
延時20分鐘行情未開盤 11/21 15:30 (東京)
2918.25億總市值10.82市盈率(靜)
4196.0最高價4057.0最低價38.79萬股成交量4100.0今開4018.0昨收16.07億成交額5410.052周最高0.62%換手率7025.15萬總股本2694.052周最低386.72每股收益TTM2593.80億流通值10360.0歷史最高10.82市盈率(靜)6244.11萬流通股489.0歷史最低383.82每股收益(静)3.46%振幅124.00股息TTM1.19市淨率100股每手2.99%股息率TTM
關於日本新藥公司
日本新藥株式會社是一家專業和仿製藥公司。Nippon 的研究和開發活動包括藥品，營養品，藥物種子的安全性和藥代動力學，基因組藥物發現和核酸藥物。該公司還開發保健食品成分，防腐劑，蛋白質製劑和香料。Nippon 將併購投資視為擴大其研究、開發、製造和行銷能力的營運成長策略的潛在組成部分。
公司介紹
公司代碼4516
公司名稱日本新藥
成立日期1919-10-01
所屬市場東證Prime
員工數量2213
年結日03-31
公司地址14, Nishinosho-Monguchi-cho Kisshoin, Minami-ku
郵編601-8550
電話075-321-1111
董事高管
- 姓名
- 職務
- 年薪
- Kazuchika Takagaki
- Director, General Manager, Research and Development and Head of Research and Development Division
- --
- Takashi Takaya
- Director and General Manager, Personnel, General Affairs, Risk Management, Compliance and Digital Transformation
- --
- Takanori Edamitsu
- Director and General Manager, Business Management and Sustainability
- --
- Shouzou Sano
- Director, Managing Director, General Manager, Sales and Marketing and Head of Sales and Marketing Division
- --
- Hitoshi Ishizawa
- Director, General Manager, Functional Food and Head of Functional Food Division
- --
- Hitomi Kimura
- Director and General Manager, Resource Procurement, Production and Assurance
- --
- Toru Nakai
- Director and President
- --
- Shigenobu Maekawa
- Chairman of the Board
- --
- Miyuki Sakurai
- Independent Director
- --
- Dr. Mayumi Nishi
- Independent Director
- --
- Yukari Kobayashi
- Independent Director
- --
- Dr. Yoshinao Wada, PhD
- Independent Director
- --
分析
目標價預測
暫無數據
熱議
日股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據